Streetbeat News

Regulatory

GOOG

GOOGL

SPY

VGK

The European Union is planning to file an antitrust case against Google's ad-tech business as early as Wednesday, according to the Wall Street Journal. EU regulators are considering pursuing a breakup of Google's ad-tech business.

Portfolio Pulse from Charles Gross

June 12, 2023 | 9:40 pm

SHY

The Federal Reserve faces a critical juncture in its interest rate hiking cycle, with the outcome of the FOMC meeting on June 14-15 holding significant implications for markets and the economy. Bond investors anticipate a pause in the upcoming June meeting, but foresee potential rate hikes resuming as early as July. The iShares 1-3 Year Treasury Bond ETF (NYSE:SHY) has fallen 1.2% in the past month, reflecting expectations of further tightening by the bond market.

Portfolio Pulse from Piero Cingari

June 12, 2023 | 9:24 pm

MF

Missfresh has received a Nasdaq notification regarding delisting due to filing delinquency. The company plans to request a hearing before the Panel and a further stay of any suspension action pending the conclusion of the hearing process.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2023 | 9:03 pm

GSQB

G Squared Ascend II (GSQB) plans to redeem public shares and cease all operations as of June 16, 2023, due to not consummating an initial business combination. The last trading day will be June 16, 2023, and the NYSE will file a Form 25 to delist its securities.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2023 | 8:45 pm

HWEL

Starton Therapeutics has received FDA authorization to proceed with its Phase 1b STAR-LLD clinical trial for multiple myeloma. The treatment will replace oral Revlimid with STAR-LLD and will be combined with Velcade and dexamethasone. Starton has signed an agreement for a business combination with Healthwell Acquisition Corp. I (NASDAQ:HWEL).

Portfolio Pulse from Benzinga Newsdesk

June 12, 2023 | 8:32 pm

KRBP

Kiromic Biopharma has appointed Brian Hungerford as its Interim CFO, according to an SEC filing. Hungerford brings extensive financial experience to the company.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2023 | 8:28 pm

UNAM

Unico American Corp has received a letter from Nasdaq stating that trading of the company's common stock will be suspended on June 15, 2023. Unico does not intend to appeal Nasdaq's determination.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2023 | 8:23 pm

ABBV

IRWD

Ironwood Pharmaceuticals has received FDA approval for LINZESS (linaclotide) to treat functional constipation in pediatric patients aged 6-17 years. The approval was based on a successful Phase III study.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2023 | 8:11 pm

SPRB

Spruce Biosciences (NASDAQ:SPRB) has announced that an abstract on the effect of tildacerfont on gonadotropins and testicular steroidogenesis in men with classic congenital adrenal hyperplasia (CAH) has been accepted for presentation at the 105th Annual Meeting of the Endocrine Society (ENDO 2023) in Chicago.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2023 | 8:09 pm

TEVA

Teva Pharmaceuticals has reached an agreement with the Attorney General of Kentucky to settle the state's price-fixing claims against the company. Teva will pay $1.407 million, and the state will dismiss all claims against Teva and its affiliates.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2023 | 8:02 pm